Invention Grant
- Patent Title: Sustained release guanfacine HCL formulation
- Patent Title (中): 持续释放胍法康HCL制剂
-
Application No.: US14888054Application Date: 2014-04-28
-
Publication No.: US09585842B2Publication Date: 2017-03-07
- Inventor: Akif Emre Tuereli , Bernd Baumstuemmler , Richard Ammer
- Applicant: SALMON PHARMA GMBH
- Applicant Address: CH Basel
- Assignee: SALMON PHARMA GMBH
- Current Assignee: SALMON PHARMA GMBH
- Current Assignee Address: CH Basel
- Agency: Jenkins, Wilson, Taylor & Hunt, P.A.
- Priority: EP13165512 20130426
- International Application: PCT/EP2014/058608 WO 20140428
- International Announcement: WO2014/174119 WO 20141030
- Main IPC: A61K9/14
- IPC: A61K9/14 ; A61K9/16 ; A61K9/20 ; A61K31/165 ; A61K31/185
Abstract:
The present invention is directed to a pharmaceutical composition comprising guanfacine or a salt thereof in nanoparticle form and at least one non-pH dependent sustained release agent. The present invention further is directed to a method of producing said nanoparticles and to nanoparticles obtained by this method.
Public/Granted literature
- US20160058708A1 SUSTAINED RELEASE GUANFACINE HCL FORMULATION Public/Granted day:2016-03-03
Information query
